Synaffix BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synaffix BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11290
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload-enhancing linker technology and HydraSpace. Synaffix generates ADCs with improved therapeutic index for the treatment of various types of cancer. The company’s hydraspace offers payload enhancing linker technology and enabling dual warhead ADCs with two mechanisms of action. Its technology can also be applied for imaging controlled delivery, vaccines, and diagnostics. The company works in partnership with other companies to develop the ADC technology platform. Synaffix is headquartered in Oss, the Netherlands.

Synaffix BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synaffix BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synaffix BV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Synaffix Raises Funds Through Series A Financing 10
Licensing Agreements 12
ADC Therapeutics Enters into Licensing Agreement with Synaffix 12
Synaffix Enters into Licensing Agreement with ADC Therapeutics 13
Synaffix BV – Key Competitors 14
Synaffix BV – Key Employees 15
Synaffix BV – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Dec 06, 2017: Synaffix Launches toxSYN, a New Platform of ADC Payloads 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Synaffix BV, Pharmaceuticals & Healthcare, Key Facts 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Deals By Therapy Area, 2012 to YTD 2018 8
Synaffix BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synaffix Raises Funds Through Series A Financing 10
ADC Therapeutics Enters into Licensing Agreement with Synaffix 12
Synaffix Enters into Licensing Agreement with ADC Therapeutics 13
Synaffix BV, Key Competitors 14
Synaffix BV, Key Employees 15

List of Figures
Synaffix BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synaffix BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • HDFC Bank Ltd:企業のM&A・事業提携・投資動向
    HDFC Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Hemostemix Inc (HEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company’s clinical-stage candidate includes ACP-01, an autologous cell therapy for t …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Teledyne Technologies Incorporated (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Incorporated (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • ReShape Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReShape Medical Inc (ReShape Medical), a subsidiary of EnteroMedics Inc is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the tr …
  • AF AB (AF B)-エネルギー分野:企業M&A・提携分析
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of customized b …
  • NeuroLogica Corp:医療機器:M&Aディール及び事業提携情報
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Marr S.P.A.
    Marr S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Marr S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vivimed Labs Ltd (VIVIMEDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Adani Enterprises Ltd (ADANIENT):石油・ガス:M&Aディール及び事業提携情報
    Summary Adani Enterprises Ltd (Adani) is a diversified company with operations in resources, logistics and energy. It has interests in various businesses such as coal trading and mining, bunkering, renewable power generation, defense and aerospace, ports and special economic zones (SEZ), logistics, …
  • Nobility Homes Inc:企業の戦略的SWOT分析
    Nobility Homes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Rawson Oil & Gas Ltd (RAW):石油・ガス:M&Aディール及び事業提携情報
    Summary Rawson Oil & Gas Ltd (Rawson), formerly Rawson Resources Ltd, is an oil and gas company that explores and develops crude hydrocarbon properties. The company’s projects include Cooper Basin, Otway Basin, Surat Basin, PEL154 and PEL155, Taranaki Basin, Cape Vogel Basin, North New Guinea Basin, …
  • Citigroup Inc:企業のM&A・事業提携・投資動向
    Citigroup Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Citigroup Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆